Stock Analysis, Dividends, Split History

CVSI / CV Sciences, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price0.36
Volume280,300.00
Market Cap ($M)32.58
Enterprise Value ($M)32.58
Book Value ($M)21.75
Book Value / Share0.02
Price / Book17.23
NCAV ($M)8.98
NCAV / Share0.01
Price / NCAV41.73
Share Statistics
Common Shares Outstanding 90,512,563
Preferred Stock Shares Outstanding 0
Common Stock Shares Outstanding 90,512,563
Scoring Models
Piotroski F-Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.30
Return on Assets (ROA)-0.26
Return on Equity (ROE)-0.37
Balance Sheet (mrq) ($M)
Assets27.03
Liabilities5.28
Quick Ratio3.52
Current Ratio4.73
Income Statement (mra) ($M)
Revenues20,679,239.00
Operating Income-4.86
Net Income-4.90
Earnings Per Share Basic-0.05
Earnings Per Share Diluted-0.05
Earnings Per Share Basic And Diluted-0.05
Cash Flow Statement (mra) ($M)
Cash From Operations3.62
Cash from Investing-2.00
Cash from Financing-2.00
Identifiers and Descriptors
CUSIP126654102
Central Index Key (CIK)1510964

Split History

Stock splits are used by CV Sciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
CVSI : CV Sciences Stock Analysis and Research Report

2017-11-20 - Asif

CV Sciences was incorporated under the name Foreclosure Solutions, Inc. in the State of Texas on December 9, 2010. On July 25, 2013, the Company’s predecessor, CannaVest Corp., a Texas corporation (“CannaVest Texas”), merged with the Company, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Company’s state of incorporation from Texas to Delaware. On January 4, 2016, the Company filed a Certificate of Amendment of Certificate of Incorporation with the Secretary of State of the State of Delaware, reflecting its corporate name change to “CV Sciences, Inc.”, effective on January 5, 2016. In addition, on January 4, 2016, the Company amended its Bylaws to reflect its corporate name change to “CV Sciences, Inc.” The Company previously operated under the corporate name of CannaVest Corp. On June 8, 2016, the Company changed its trading symbol from CANV to CVSI, and continues to be traded on the OTC: QB. The change in corporate name was undertaken in conn...

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2018 Results - Earnings Call Transcript

2018-08-01 seekingalpha
Greetings and welcome to the CV Sciences' 2018 Second Quarter Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. (0-1)

20 Small-Cap Stocks With the Potential for Outsized Gains | InvestorPlace

2018-07-12 investorplace
Some market components, such as small-capitalization companies, require little coaxing. Whether it’s their potential to produce incredible gains, or the chance to get in early on a burgeoning industry, small-cap stocks present enticing opportunities. And while we should all be aware of their highly risky reputation, most investment strategies benefit from their inclusion. (86-9)

30 Marijuana Stocks to Buy as the Future Turns Green

2018-05-14 investorplace
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. (149-29)

Alcohol Stocks Fighting To Stay Relevant In A Marijuana Stock Market?

2018-04-27 seekingalpha
For 30 days the marijuana industry has seen some of the biggest government support to date. (43-1)

CV Sciences, Inc. 2017 Q4 - Results - Earnings Call Slides

2018-04-02 seekingalpha
The following slide deck was published by CV Sciences, Inc. in conjunction with their 2017 Q4 earnings call. (3-2)

Silicon Investor Message Boards

This table lists all message boards related to CVSI / CV Sciences, Inc. on message board site Silicon Investor.

CBD oil CBD oil CBD oil
CUSIP: 126654102